Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization

Alzheimer’s disease (AD) is a fatal neurodegenerative disorder associated with severe dementia, progressive cognitive decline, and irreversible memory loss. Although its etiopathogenesis is still unclear, the aggregation of amyloid-β (Aβ) peptides into supramolecular structures and their accumulatio...

Full description

Bibliographic Details
Main Authors: Massimiliano Cuccioloni, Valentina Cecarini, Laura Bonfili, Riccardo Pettinari, Alessia Tombesi, Noemi Pagliaricci, Laura Petetta, Mauro Angeletti, Anna Maria Eleuteri
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/15/8710
_version_ 1797432868063936512
author Massimiliano Cuccioloni
Valentina Cecarini
Laura Bonfili
Riccardo Pettinari
Alessia Tombesi
Noemi Pagliaricci
Laura Petetta
Mauro Angeletti
Anna Maria Eleuteri
author_facet Massimiliano Cuccioloni
Valentina Cecarini
Laura Bonfili
Riccardo Pettinari
Alessia Tombesi
Noemi Pagliaricci
Laura Petetta
Mauro Angeletti
Anna Maria Eleuteri
author_sort Massimiliano Cuccioloni
collection DOAJ
description Alzheimer’s disease (AD) is a fatal neurodegenerative disorder associated with severe dementia, progressive cognitive decline, and irreversible memory loss. Although its etiopathogenesis is still unclear, the aggregation of amyloid-β (Aβ) peptides into supramolecular structures and their accumulation in the central nervous system play a critical role in the onset and progression of the disease. On such a premise, the inhibition of the early stages of Aβ aggregation is a potential prevention strategy for the treatment of AD. Since several natural occurring compounds, as well as metal-based molecules, showed promising inhibitory activities toward Aβ aggregation, we herein characterized the interaction of an organoruthenium derivative of curcumin with Aβ(1–40) and Aβ(1–42) peptides, and we evaluated its ability to inhibit the oligomerization/fibrillogenesis processes by combining in silico and in vitro methods. In general, besides being less toxic to neuronal cells, the derivative preserved the amyloid binding ability of the parent compound in terms of equilibrium dissociation constants but (most notably) was more effective both in retarding the formation and limiting the size of amyloid aggregates by virtue of a higher hindering effect on the amyloid–amyloid elongation surface. Additionally, the complex protected neuronal cells from amyloid toxicity.
first_indexed 2024-03-09T10:07:53Z
format Article
id doaj.art-d54c92af4ef2401ba4e6558195c45265
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T10:07:53Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d54c92af4ef2401ba4e6558195c452652023-12-01T22:58:35ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-08-012315871010.3390/ijms23158710Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) DerivatizationMassimiliano Cuccioloni0Valentina Cecarini1Laura Bonfili2Riccardo Pettinari3Alessia Tombesi4Noemi Pagliaricci5Laura Petetta6Mauro Angeletti7Anna Maria Eleuteri8School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, MC, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, MC, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, MC, ItalySchool of Pharmacy, University of Camerino, Via Sant’Agostino, 62032 Camerino, MC, ItalySchool of Science and Technology, University of Camerino, Via Sant’Agostino, 62032 Camerino, MC, ItalySchool of Pharmacy, University of Camerino, Via Sant’Agostino, 62032 Camerino, MC, ItalySchool of Science and Technology, University of Camerino, Via Sant’Agostino, 62032 Camerino, MC, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, MC, ItalySchool of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, MC, ItalyAlzheimer’s disease (AD) is a fatal neurodegenerative disorder associated with severe dementia, progressive cognitive decline, and irreversible memory loss. Although its etiopathogenesis is still unclear, the aggregation of amyloid-β (Aβ) peptides into supramolecular structures and their accumulation in the central nervous system play a critical role in the onset and progression of the disease. On such a premise, the inhibition of the early stages of Aβ aggregation is a potential prevention strategy for the treatment of AD. Since several natural occurring compounds, as well as metal-based molecules, showed promising inhibitory activities toward Aβ aggregation, we herein characterized the interaction of an organoruthenium derivative of curcumin with Aβ(1–40) and Aβ(1–42) peptides, and we evaluated its ability to inhibit the oligomerization/fibrillogenesis processes by combining in silico and in vitro methods. In general, besides being less toxic to neuronal cells, the derivative preserved the amyloid binding ability of the parent compound in terms of equilibrium dissociation constants but (most notably) was more effective both in retarding the formation and limiting the size of amyloid aggregates by virtue of a higher hindering effect on the amyloid–amyloid elongation surface. Additionally, the complex protected neuronal cells from amyloid toxicity.https://www.mdpi.com/1422-0067/23/15/8710Alzheimer’s diseaseamyloid-βcurcuminorganoruthenium derivativeanti-aggregating molecule
spellingShingle Massimiliano Cuccioloni
Valentina Cecarini
Laura Bonfili
Riccardo Pettinari
Alessia Tombesi
Noemi Pagliaricci
Laura Petetta
Mauro Angeletti
Anna Maria Eleuteri
Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
International Journal of Molecular Sciences
Alzheimer’s disease
amyloid-β
curcumin
organoruthenium derivative
anti-aggregating molecule
title Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
title_full Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
title_fullStr Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
title_full_unstemmed Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
title_short Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
title_sort enhancing the amyloid β anti aggregation properties of curcumin via arene ruthenium ii derivatization
topic Alzheimer’s disease
amyloid-β
curcumin
organoruthenium derivative
anti-aggregating molecule
url https://www.mdpi.com/1422-0067/23/15/8710
work_keys_str_mv AT massimilianocuccioloni enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT valentinacecarini enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT laurabonfili enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT riccardopettinari enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT alessiatombesi enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT noemipagliaricci enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT laurapetetta enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT mauroangeletti enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization
AT annamariaeleuteri enhancingtheamyloidbantiaggregationpropertiesofcurcuminviaarenerutheniumiiderivatization